MedPath

effect of talahridaya marma on blood pressure

Not Applicable
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Registration Number
CTRI/2022/03/040845
Lead Sponsor
Banaras Hindu University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

from the cardiology OPD of SSH BHU Freshly diagnosed cases of Stage 1 Primary hypertension both male and female included between the age group of 40 to 60 years.

Exclusion Criteria

secondary hypertension will be excluded

patients with terminal illness like cancer, HIV, etc. will be excluded.Patients with infective diseases with systemic manifestation will be excluded.Patients with chronic diseases except metabolic syndrome will be excluded such as Rheumatoid Arthritis, Bronchial asthma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Talahridaya marma Stimulation <br/ ><br>may have asssed on systolic and diastolic blood pressure of stage 1 primary hypertension casesTimepoint: Lowering of blood pressure is the primary outcome and it will be measured/assessed after 15 days from first visit and then it will be assessed at 1 month and then after 3 month
Secondary Outcome Measures
NameTimeMethod
talahridaya marma point assessmentTimepoint: 1 day to 45 days
© Copyright 2025. All Rights Reserved by MedPath